• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Bausch Health Companies Inc (NY: BHC )

    8.760 UNCHANGED
    Streaming Delayed Price Updated: 7:00 PM EDT, Apr 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 8.760
    Bid (Size) 7.610 (1)
    Ask (Size) 9.150 (1)
    Prev. Close 8.760
    Today's Range 8.760 - 8.760
    52wk Range 5.700 - 11.46
    Shares Outstanding 358,808,755
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Bausch Health to Announce First-Quarter 2024 Results on May 2
    Via ACCESSWIRE
    Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029
    Via ACCESSWIRE

    Performance

    YTD
    +12.60%
    +12.60%
    1 Month
    -15.77%
    -15.77%
    3 Month
    +6.96%
    +6.96%
    6 Month
    +28.45%
    +28.45%
    1 Year
    +16.64%
    +16.64%

    More News

    Read More
    Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan
    Via ACCESSWIRE
    Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals
    Via ACCESSWIRE
    Preview: Bausch Health Companies's Earnings
    Via Benzinga
    Salix Announces 2024 Gastrointestinal Health Scholars Program
    Via ACCESSWIRE
    CORRECTION BY SOURCE: Solta Medical's Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China
    Via ACCESSWIRE
    Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for (Pr)UCERIS(R) (budesonide) Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to Moderate Distal Ulcerative Colitis in Adults
    Via ACCESSWIRE
    Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations
    Via ACCESSWIRE
    Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR(R) (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma
    Via ACCESSWIRE
    New Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How To Prepare for the Procedure
    Via ACCESSWIRE
    Bausch Health Companies to Present at Cowen Annual Health Care Conference
    Via ACCESSWIRE
    Solta Medical’s Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China
    Via ACCESSWIRE
    Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis
    Via ACCESSWIRE
    RBC Capital Maintains Sector Perform Rating for Bausch Health Companies: Here's What You Need To Know
    Via Benzinga
    Bausch Health Announces Fourth-Quarter and Full-Year 2023 Results
    Via ACCESSWIRE
    A 'Toxic Byproduct of an Imperfect Higher Education System' — Famous Short Seller Known as 'The Assassin' Strikes Her Newest Target
    Via Benzinga
    Bausch Health Announces Board Refreshment
    Via ACCESSWIRE
    Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22
    Via ACCESSWIRE
    CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel for the Treatment of Acne Vulgaris Now Available in the U.S.
    Via ACCESSWIRE
    Court of Appeals for the Federal Circuit Hears Oral Arguments on Patent Dispute
    Via ACCESSWIRE
    DUOBRII(TM) Lotion to Treat Moderate to Severe Plaque Psoriasis Now Available Through Quebec’s Public Drug Plan
    Via ACCESSWIRE
    3 cheap 'stock'-ing stuffers Wall Street is bullish on
    Via MarketBeat
    Topics Stocks
    Exposures US Equities
    Salix in Collaboration with The U.S. Pain Foundation and the International Foundation for Gastrointestinal Disorders Establish the Inaugural Opioid-Induced Constipation (OIC) Awareness Day
    Via ACCESSWIRE
    Bausch Health Companies Inc. (NYSE:BHC) Long Term Shareholder Notice: Investigation of Potential Wrongdoing
    Via SBWire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.